DUSP4 and melanoma: This suggests that DUSP4 could be an effective target across a larger panel of melanoma cell lines.Consistent with findings from the CRISPR‐Cas9 screens, inactivation of DUSP4 did not induce a growth disadvantage in the IGR1 cell line, showing heterogeneity between different melanoma cell lines with respect to fitness effects.